0.0950
+0.0250
+(35.71%)
At close: January 10 at 1:03:53 PM EST
Breakdown
TTM
10/31/2023
10/31/2022
10/31/2021
Operating Cash Flow
-172.7750
-198.2560
-1,819.4550
-2,982.3130
Investing Cash Flow
223.1010
198.1010
-80.0000
2,130.4100
Financing Cash Flow
--
--
--
2,751.7700
End Cash Position
0.4980
0.2570
0.4120
1,899.8670
Capital Expenditure
--
--
--
-43.9000
Issuance of Capital Stock
--
--
--
103.7500
Issuance of Debt
--
--
--
2,648.0200
Free Cash Flow
-172.7750
-198.2560
-1,819.4550
-3,026.2130
10/31/2021 - 5/27/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
26CA.BE ImmunityBio Inc
2.3680
-6.70%
BETR.CN BetterLife Pharma Inc.
0.1150
-4.17%
KDST.TA Kadimastem Ltd
1,546.00
+0.32%
BLAB.CN Britannia Life Sciences Inc.
0.0850
0.00%
NRX.V NurExone Biologic Inc.
0.6800
+4.62%
HEM.V Hemostemix Inc.
0.2400
+20.00%
LVTX LAVA Therapeutics N.V.
0.9758
-5.26%
ORGS Orgenesis Inc.
1.8000
0.00%
VCNX Vaccinex, Inc.
1.1500
+21.05%
GTBP GT Biopharma, Inc.
2.6500
+3.92%